Every 424B that SmartKem, Inc. (SMTK) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow SMTK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SMTK filings page.
SmartKem, Inc. is registering up to 160,260,999 shares of its Common Stock for resale by selling stockholders. The registered shares comprise 47,596,389 Additional Conversion Shares, 10,753,615 Additional Warrant Shares and 101,910,995 Additional RRA Shares. The Company will not receive proceeds from sales by the selling stockholders; the Company will receive proceeds only if Warrants are exercised for cash. The registration covers shares issuable upon conversion of Series A Preferred Stock and upon exercise of Warrants issued in private placements and an Additional Closing on June 22, 2026. The prospectus notes trading on Nasdaq under the symbol SMTK and discloses a last reported sale price of $0.2364 per share on July 1, 2026. The document also summarizes recent financings, including a senior secured notes financing of $3,750,000 (original principal) and an equity line commitment up to $500,000,000 or 19.99% of outstanding shares (Keystone).
SmartKem, Inc. registers 126,453,978 shares of Common Stock for resale by selling stockholders, comprised of 101,910,996 Conversion Shares issuable upon conversion of Series A Convertible Preferred Stock and 24,542,982 Warrant Shares issuable upon exercise of warrants.
The prospectus states the company is not selling any shares for its own account and will not receive proceeds from resales by the selling stockholders, although SmartKem will receive net proceeds from any warrants exercised for cash. The filing summarizes related financings including an equity line purchase agreement providing up to $500,000,000 or 19.99% of outstanding shares (whichever is less), senior secured notes with an original principal of $3,750,000 and related security interests, and a settlement involving a $300,000 cash payment and assignment of certain patents.
SmartKem, Inc. registers up to 146,776,707 shares of common stock for resale by Keystone Capital Partners, LLC under a March 30, 2026 Purchase Agreement. These shares may be issued to Keystone at the Company's discretion and then resold by Keystone. The Purchase Agreement includes a maximum committed purchase of up to $500 million or 19.99% of outstanding common stock at the time of the agreement, subject to Nasdaq limits and other conditions. The prospectus states the Company will not receive proceeds from resales by Keystone via this registration, though the Company may receive proceeds if it elects to sell shares to Keystone under the Purchase Agreement.
SmartKem, Inc. is offering 11,365,350 shares of Common Stock in a registered direct offering at a purchase price of $0.2303 per share, for aggregate gross proceeds of $2,617,440, in a sale to certain institutional investors.
Net proceeds are estimated at approximately $2,457,440 to be used for working capital and general corporate purposes. Shares outstanding were 9,837,561 as of March 20, 2026, and the company estimates 21,202,911 shares outstanding after the offering. The offering is expected to settle on or about March 23, 2026.
SmartKem, Inc. is offering 677,129 shares of common stock and 683,871 pre-funded warrants to purchase 683,871 shares of common stock in a registered direct financing to an institutional investor. The common stock is priced at $0.50 per share and each pre-funded warrant at $0.4999 with a $0.0001 exercise price.
Gross proceeds are expected to be $680,500, with estimated net proceeds of approximately $610,500, which the company plans to use for working capital and general corporate purposes. Shares of common stock outstanding were 6,839,689 as of January 29, 2026, and are expected to be 8,200,689 after this offering, assuming full exercise of the pre-funded warrants. The pre-funded warrants are immediately exercisable and subject to a 4.99% or, at the purchaser’s election, 9.99% beneficial ownership cap.